These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1577522)

  • 21. Evaluation of a guinea pig model to assess interference in the immunogenicity of different components of a combination vaccine comprising diphtheria, tetanus and acellular pertussis (DTaP) vaccine and haemophilus influenzae type b capsular polysaccharide conjugate vaccine.
    Gupta RK; Anderson R; Cecchini D; Rost B; Xu J; Gendreau K; Saroff DL; Marchant C; Siber GR
    Biologicals; 1999 Jun; 27(2):167-76. PubMed ID: 10600208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on the optimal conditions for inactivation of Bordetella pertussis organisms with glutaraldehyde for preparation of a safe and potent pertussis vaccine.
    Gupta RK; Saxena SN; Sharma SB; Ahuja S
    Vaccine; 1988 Dec; 6(6):491-6. PubMed ID: 2907704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The stability of bacterial vaccines at elevated temperatures.
    Stainer DW; Hart FE
    Dev Biol Stand; 1978; 41():249-53. PubMed ID: 753653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can Haemophilus influenzae type b-tetanus toxoid conjugate vaccine be combined with diphtheria toxoid-pertussis vaccine-tetanus toxoid?
    Scheifele D; Barreto L; Meekison W; Guasparini R; Friesen B
    CMAJ; 1993 Oct; 149(8):1105-12. PubMed ID: 8221449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of freezing on DPT and DPT-IPV vaccines, adsorbed.
    Dimayuga R; Scheifele D; Bell A
    Can Commun Dis Rep; 1995 Jun; 21(11):101-3. PubMed ID: 7647743
    [No Abstract]   [Full Text] [Related]  

  • 26. Validation of the toxin-binding inhibition (ToBI) test for the estimation of the potency of the tetanus toxoïd component in vaccines.
    van der Gun J; Akkermans A; Hendriksen C; van de Donk H
    Dev Biol Stand; 1996; 86():199-206. PubMed ID: 8785949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assay of pertussis vaccine reactivity factors by measurement of the paw swelling response, endotoxin and histamine-sensitizing factor.
    Vuolo AM; Lustigman B
    Biologicals; 1993 Mar; 21(1):45-52. PubMed ID: 8217117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative study of the potency of the pertussis component in DPT vaccine produced in stationary culture and by fermentation].
    Galicia O; Villalva H; Pérez A; Pérez S; Medina A
    Salud Publica Mex; 1981; 23(6):607-11. PubMed ID: 6278658
    [No Abstract]   [Full Text] [Related]  

  • 29. [Improvement in the laboratory methods of assessing the safety of the of the pertussis component of DPT vaccine adsorbed].
    Chuprinina RP; Il'nitskaia EA; Polikar A; Vŭlchev V; Mikhaĭlova V; Niedermayer N; Pruchová J; Kardymowics B; Kudelski Z; Rymkewics D
    Zh Mikrobiol Epidemiol Immunobiol; 1992 Jan; (1):28-33. PubMed ID: 1414103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity of glutaraldehyde inactivated pertussis vaccine.
    Gupta RK; Saxena SN; Sharma SB; Ahuja S
    Vaccine; 1990 Dec; 8(6):563-8. PubMed ID: 2128428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on the minimal number of animals required to achieve assurance of satisfactory potency in diphtheria and tetanus vaccines.
    Knight PA; Roberts PA
    Dev Biol Stand; 1986; 65():245-53. PubMed ID: 3493931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of different concentrations of diphtheria toxoid & aluminum phosphate on potency of diphtheria component in DPT vaccines.
    Gupta P; Saxena SN; Kumar A; Gupta P
    Indian J Med Res; 1990 May; 91():171-3. PubMed ID: 2118880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Study on immune persistency of combined diphtheria-pertussis-tetanus (DPT) triple vaccine].
    Diao L
    Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Feb; 13(1):26-9. PubMed ID: 1581951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The determination of the protective potency of the diphtheria component in combined vaccines by the indirect hemagglutination (IHA) method].
    Unver SD; Ozcengiz E
    Mikrobiyol Bul; 1990 Oct; 24(4):327-35. PubMed ID: 2287290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Humoral immunity of dTap-IPV vaccine (REPEVAX®) administered one month after dT-IPV vaccine (REVAXIS®) in adults with unknown vaccination history.
    Larnaudie S; Guiso N; Baptiste C; Desaint C; Desforges L; Lebon P; Soubeyrand B; Launay O
    Hum Vaccin; 2010 Oct; 6(10):829-34. PubMed ID: 20864810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of a new combined inactivated DPT-polio vaccine.
    Drucker J; Soula G; Diallo O; Fabre P
    Dev Biol Stand; 1986; 65():145-51. PubMed ID: 3030861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. STABILIZATION OF PERTUSSIS VACCINE IN THE PRESENCE OF BENZETHONIUM CHLORIDE.
    OLSON BH; ELDERING G; GRAHAM B
    J Bacteriol; 1964 Mar; 87(3):543-6. PubMed ID: 14127568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concurrent administration of rhesus rotavirus tetravalent (RRV-TV) vaccine with pentavalent diphtheria-pertussis-tetanus-Haemophilus influenzae beta-inactivated polio and hepatitis B vaccines.
    Vesikari T; Joensuu J; Baer M; Käyhty H; Olander RM; Sormunen H; Miettinen A; Ward RL; Guillot T
    Acta Paediatr; 1999 May; 88(5):513-20. PubMed ID: 10426173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Heat stability of potency of bacterial vaccines and the titer of tetanus antitoxin of Polish production].
    Aleksandrowicz J; Banach W; Bucholc B; Fiejka M; Gołobów M; Janaszek W; Kudelski Z; Rymkiewicz D; Sawicki J; Słowikowska M
    Przegl Epidemiol; 1990; 44(4):333-5. PubMed ID: 2100817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Development studies of lyophilized standard diphtheria-tetanus-pertussis vaccines].
    Ozcengiz E; Unver D; Cayan HH; Atakan Ablay P; Kanik E
    Mikrobiyol Bul; 2007 Apr; 41(2):165-73. PubMed ID: 17682702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.